| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7423019 Chimeric glucagon-like peptide for prevention and treatment of pancreatic disorders |
| 09/09/2008 | US7423014 Insulin conjugates for treating diabetes mellitus |
| 09/09/2008 | US7422849 Hybridizing sample with a nucleic acid molecule to a transcript of gene wherein said transcript is RNA or cDNA; determining hybridization as a determination of expression of gene |
| 09/09/2008 | US7422764 Matrix-forming composition containing pectin |
| 09/09/2008 | US7422763 Acid controlled induced viscosity fiber system and uses thereof |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | CA2508871C Crystalline form f of atorvastatin hemi-calcium salt |
| 09/09/2008 | CA2460865C Quinoline derivatives as neuropeptide y antagonists |
| 09/09/2008 | CA2397960C Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
| 09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 09/09/2008 | CA2336712C Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 09/09/2008 | CA2252163C D-proline derivatives |
| 09/09/2008 | CA2181689C Guanylhydrazones for treating inflammatory conditions |
| 09/04/2008 | WO2008106128A2 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 09/04/2008 | WO2008105731A1 New use of nitrites and nitrates and compositions containing these |
| 09/04/2008 | WO2008105607A1 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists |
| 09/04/2008 | WO2008105583A1 Crude exopolysaccharides produced from tremella fuciformis mycellium having hypoglycemic activity and preparation method thereof |
| 09/04/2008 | WO2008105533A1 Adiponectin secretion-stimulating agent comprising capsinoid compound |
| 09/04/2008 | WO2008105436A1 TUMOR NECROSIS FACTOR-α INHIBITOR AND PROSTAGLANDIN SYNTHASE-2 INHIBITOR |
| 09/04/2008 | WO2008105408A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents |
| 09/04/2008 | WO2008105386A1 Rexinoid compound having alkoxy group |
| 09/04/2008 | WO2008105384A1 Citrulline-containing tablet |
| 09/04/2008 | WO2008105368A1 Amino acid composition |
| 09/04/2008 | WO2008105340A1 Liquid nutritional food and method of producing the same |
| 09/04/2008 | WO2008105326A1 Process for production of 2-imino-4-thiazolidinone derivative and 2,4-thiazolidinedione derivative |
| 09/04/2008 | WO2008105325A1 Citrulline-containing beverage |
| 09/04/2008 | WO2008104975A2 Combination therapy, composition and methods for the treatment of cardiovascular disorders |
| 09/04/2008 | WO2008104875A1 Oxazolidinones as cholesterol absorption inhibitors |
| 09/04/2008 | WO2008104279A1 Imidazo[1,2-a]azines and their use as pharmaceuticals |
| 09/04/2008 | WO2008104239A1 Composition useful for the treatment of type 2 diabetes |
| 09/04/2008 | WO2008104187A1 Pharmaceutical composition comprising glibenclamide coenzyme q10 and vitamins for the treatment of diabetes |
| 09/04/2008 | WO2008104124A1 Screening method of combination pharmaceuticals, pharmaceuticals obtained by the method and uses thereof |
| 09/04/2008 | WO2008104084A1 Linoleoyl-containing phospholipids and methods for their use |
| 09/04/2008 | WO2008074834A3 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 09/04/2008 | US20080214870 Method of Preparing Amine Stereoisomers |
| 09/04/2008 | US20080214674 Acylhydrazone derivatives and the use thereof in the inhibition, regulation and/or modulation of kinase signal transduction |
| 09/04/2008 | US20080214668 Use of retinoids to treat high blood pressure and other cardiovascular disease |
| 09/04/2008 | US20080214656 Compounds With Diphenoyl-Structure For the Treatment of Immune Diseases |
| 09/04/2008 | US20080214652 Methods of treating hyperlipidemia |
| 09/04/2008 | US20080214651 Administering Atorvastatin; purer, more stable, more advantageous manufacturing properties than the amorphous product |
| 09/04/2008 | US20080214650 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution |
| 09/04/2008 | US20080214633 (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetanilide and a carrier; diabetes, anti-obesity and anti-hyperlipemia |
| 09/04/2008 | US20080214625 Administering [3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide; hypertension, hyperlipidemia, hyperuricemia, gout and hypercoagulability |
| 09/04/2008 | US20080214621 Metabolic disorders; antidiabetic agents; obesity; hypotensive agents; antilipemic agents; 1-Cyclohexyl-3-naphthalen-2-ylmethyl-pyrrolidin-2-one |
| 09/04/2008 | US20080214616 Pyridine Derivatives as Dipeptedyl Peptidase Inhibitors |
| 09/04/2008 | US20080214610 Thiazolylimidazole Derivatives and Their Use as Inhibitors of Microsmal Triglyceride Transfer Protein |
| 09/04/2008 | US20080214607 Heteroaromatic quinoline compounds |
| 09/04/2008 | US20080214605 to potentiate the effects of the other CNS agents; probes for the localization of cell surface receptors;3-(methylthio)-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide; depression, anxiety, schizophrenia, cognitive disorders, obesity, irritable bowel syndrome, emesis, pre-eclampsia, etc. |
| 09/04/2008 | US20080214601 2-alkylbenzoxazole carboxamides as 5ht3 modulators |
| 09/04/2008 | US20080214599 Use of Par-1/Par-4 Inhibitors for Treating or Preventing Vascular Diseases |
| 09/04/2008 | US20080214597 Tricyclic Lactam Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 09/04/2008 | US20080214593 Tetracyclic amino and carboxamido compounds and methods of use thereof |
| 09/04/2008 | US20080214586 2-Amino-4-Phenylquinazoline Derivatives and the Use Thereof as Hsp90 Modulators |
| 09/04/2008 | US20080214574 Inhibition of the Activity of the Capsaicin Receptor in the Treatment of Obesity or Obesity-Related Diseases and Disorders |
| 09/04/2008 | US20080214570 Therapeutic Agents |
| 09/04/2008 | US20080214559 Compounds with a combination of cannabinoid cb1 antagonism and serotonin reuptake inhibition |
| 09/04/2008 | US20080214556 Stabilizing with intravenous infusion followed by oral sustained release maintenance formulation; reducing blood plasma HbA1x levels |
| 09/04/2008 | US20080214544 N-(4-(6-(1-methyl-6-oxo-2-(phenylamino)-1,6-dihydropyrimidin-5-yl)pyridin-3-yloxy)pyridin-2-yl)pyrrolidine-1-carboxamide; anticarcinogenics, antiproliferatives, angiogenesis inhibitors; hepatocyte growth factor mediated diseases |
| 09/04/2008 | US20080214540 3-[(phenyl or benzothiazol-2-yl)methyl]indole-N-acetic acids and esters; analgesics; aldose reductase inhibitors; diabetes complications including cataracts, retinopathy, nephropathy, and neuropathy; side effect reduction |
| 09/04/2008 | US20080214531 Administering combination of niacin and meloxicam; reducing prostaglandin levels |
| 09/04/2008 | US20080214520 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder |
| 09/04/2008 | US20080214499 Lowering lipids in a living body by use of a cyclic tetrasaccharide represented by formula of cyclo{>6)- alpha -D-glucopyranosyl-(1>3)- alpha -D-glucopyranosyl-(1>6)- alpha -D-glucopyranosyl-(1>3)- alpha -D-glucopyranosyl-(1>}, and/or glycosylated compound(s) thereof |
| 09/04/2008 | US20080214479 Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
| 09/04/2008 | US20080214469 Novel Biologically Active Peptides and Their New Uses |
| 09/04/2008 | US20080214441 Administering betaines, lipidic betaines, and antidiabetic agent (metformin) such as sulfonylureas, biguanides, glitazones, a-glucosidase inhibitors, potassium channel antagonists, aldose reductase inhibitors, glucagon antagonists, activators of RXR, insulin therapy or other anti-obesity agents |
| 09/04/2008 | US20080214440 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity |
| 09/04/2008 | US20080213886 Albumin fusion proteins |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213414 with a standarized phaseolamine content and a standardized 3-methylethergalangin content; alpha-amylase inhibitor |
| 09/04/2008 | US20080213413 fatty acid esters of vanillyl alcohol, capsiate, dihydrocapsiate, etc and at least one cyclodextrin; treating obesity; stably pulverized, soluble in water, easily handled |
| 09/04/2008 | US20080213400 Combinations of Chromium with Antidiabetics for Glucose Metabolism Disorders |
| 09/04/2008 | US20080213378 Atorvastatin; lovastatin; a keto analog of mevinolin; pravastatin; simvastatin; velostatin; fluindostatin; cetyl pyridinium, polymer, biopolymer surface stabilizers; suspensions, gels, aerosols, ointments, creams, controlled release; oral, pulmonary, rectal, opthalmic; improved pharmacokinetic profiles |
| 09/04/2008 | US20080213362 Diuretic treatment of edema and congestive heart failure; thiazolidinedione anti-diabetic agent, pioglitazone and rosiglitazone; three layered tablet; not worsen blood sugar levels or glycemic status; dose of about 2 mg or less of torsemide |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213288 Glucagon-like peptides (GLP-1); for treatment/prevention of diabetes or autoimmune diseases |
| 09/04/2008 | US20080213240 RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK |
| 09/04/2008 | US20080213234 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/04/2008 | US20080213226 Using nitrosomonas mixture in powder, cream, stick and/or salve to oxidize nitric oxide and nitric oxide precursors in order to treat and/or prevent vascular, nervous system, blood and eating disorders |
| 09/04/2008 | DE102004059460B4 Zusammensetzung mit verdauungsfördernder Wirkung Composition with digestive effect |
| 09/04/2008 | CA2679416A1 Combination therapy, composition and methods for the treatment of cardiovascular disorders |
| 09/04/2008 | CA2679300A1 Amino acid composition |
| 09/04/2008 | CA2679185A1 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 09/04/2008 | CA2678746A1 Composition useful for the treatment of type 2 diabetes |
| 09/04/2008 | CA2678735A1 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 09/04/2008 | CA2678577A1 Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 09/04/2008 | CA2678097A1 New use of nitrites and nitrates and compositions containing these |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964855A1 Mineral absorption enhancer, food and feeding stuff |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964841A1 Imidazo[1,2-a]azine and their use as pharmaceuticals |
| 09/03/2008 | EP1964570A1 Pharmaceutical compound to protect against allergies and inflammatory illnesses |
| 09/03/2008 | EP1964562A1 Pharmaceutical compositions containing derivative substances of thiazolidinediones combined with a biguanide for use in type 2 diabetes mellitus |
| 09/03/2008 | EP1964558A1 Pharmaceutical compositions containing intestinal lipase inhibiting substances combined with a chromium dinicotinate o-coordinated complex for use in the treatment and control of obesity and overweight |
| 09/03/2008 | EP1964555A1 Pharmaceutical compositions containing substances that inhibit the reuptake of noradrenaline, dopamine and serotonin, which are combined with an amino acid for the treatment of obesity and overweight |
| 09/03/2008 | EP1963331A1 Azepinoindole derivatives as pharmaceutical agents |
| 09/03/2008 | EP1963318A1 Pyrrolo[2,3-c]pyridine derivatives |
| 09/03/2008 | EP1963294A1 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase) |
| 09/03/2008 | EP1963293A1 1-orthofluorophenyl substituted 1, 2 , 5-thiazolidinedione derivatives as ptp-as inhibitors |